Jess Roper's most recent trade in Revelation Biosciences Inc was a trade of 15,625 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Oct. 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revelation Biosciences Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 1.28 per share. | 29 Oct 2025 | 15,625 | 15,686 | - | 1.3 | 20,000 | Common Stock |
| Revelation Biosciences Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 181 | 183 | - | 3.9 | 700 | Common Stock |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 512,821 | 554,596 | - | - | Restricted Stock Unit | |
| Revelation Biosciences Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 6,356 | 6,356 | - | - | Stock Option (Right to Buy) | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 41,775 | 41,775 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jess Roper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Apr 2022 | 345 | 0 | - | - | Series G Preferred Stock | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 138,000 | 138,000 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 111,337 | 111,337 | - | - | Stock Appreciation Right |